That holds doubly true for Medicago, a Canadian biopharma company. Medicago uses plants to produce vaccine and therapeutic candidates, and the platform has found new purpose in the age of coronavirus.

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...

Medicago’s CEO. “Our proven plant-based technology is capable of contributing to the collective solution to this public health emergency,” he added. One of the lead vaccine candidates ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco plant and developed by Medicago Inc., the Osaka-based company’s ...

Beneficial relationships between plants and soil microbes play a critical ... Researchers demonstrated that the mutation in legumes like Medicago truncatula significantly boosted symbiosis with ...

We can hijack this process to give plants genetic instructions for new proteins. Canadian company Medicago has produced a candidate covid-19 vaccine using this method. Within 20 days of obtaining ...